Current Paediatrics
Volume 12, Issue 4 , Pages 290-297, August 2002

The management of haemoglobinopathies

  • Manoj Raghavan (Specialist Registrar in Haematology)

      Affiliations

    • Department of Haematology, Great Ormond Street, Hospital for Children, Great Ormond Street, London, WC1N 3JH, UK
  • ,
  • Sally C. Davies (Consultant Haematologist)

      Affiliations

    • Imperial College Faculty of Medicine at Central Middlesex Hospital, Acton Lane, Park Royal, London, NW10 7NS, UK
    • Correspondence to: SCD. Imperial College Faculty of Medicine at Central Middlesex Hospital, Acton Lane, Park Royal, London NW10 7NS, UK. Tel.: +44 (0)20 7725 5408; Fax: +44 (0)20 7725 5467; E-mail: sally.davies@doh.gsi.gov.uk

Abstract 

Sickle cell disease (SCD) and thalassaemia major are the most important syndromes of the haemoglobinopathies. Complications of SCD can be life threatening and include stroke, hyposplenism and vaso-occlusive crises. Treatment of SCD is generally supportive or by transfusion, hydroxyurea or bone marrow transplant (BMT). β Thalassaemia major is treated with transfusion and chelation for the resulting iron overload which is the cause of most morbidity, with BMT the only curative procedure.

Keywords: haemoglobinopathies, Sickle cell, thalassaemia, Clinical Management, transfusion, hydroxyurea

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0957-5839(02)90301-5

doi:10.1054/cupe.2002.0301

Current Paediatrics
Volume 12, Issue 4 , Pages 290-297, August 2002